Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

INSP stock hub

Inspire Medical Systems, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

INSPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.3B
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
INSP
In the news

Latest news · INSP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E44.5
P25 12.3P50 18.4P75 33.1
Trailing P/E9.9
P25 14.9P50 23.2P75 38.5
ROE18.4
P25 -105.6P50 -46.5P75 -3.1
ROIC9.8
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All INSP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
239
Groups with data
11
Currency
USD
Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001609550
Company name
Inspire Medical Systems, Inc.
Country
United States
Country code
US
Cusip
457730109
Employees
1,333
Employees Change
87%
Employees Change Percent
6.98
Enterprise value
$1B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2018-05-03
Isin
US4577301090
Last refreshed
2026-05-10
Market cap
$1.3B
Market cap category
Small-Cap
Price
$44.26
Price currency
USD
Rev Per Employee
686,606.9x
Sector
Healthcare
Sic
3841
Symbol
INSP
Website
https://www.inspiresleep.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
10.28%
EV Earnings
7.79x
EV Sales Forward
1.01x
EV/EBIT
19.89x
EV/EBITDA
15.16x
EV/FCF
10.56x
EV/Sales
1.12x
FCF yield
7.58%
Forward P/E
44.48x
P/B ratio
1.61x
P/E ratio
9.9x
P/S ratio
1.39x
PE Ratio3 Y
147.26x
PS Forward
1.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
5.61%
EBITDA Margin
7.36%
FCF margin
10.57%
Gross margin
85.78%
Gross Profit
$785.1M
Gross Profit Growth
10.39%
Gross Profit Growth Q
3.7%
Gross Profit Growth3 Y
26.22%
Gross Profit Growth5 Y
47.08%
Net Income
$131.1M
Net Income Growth
97.18%
Net Income Growth Years
3%
Pretax Margin
6.99%
Profit Margin
14.33%
Profit Per Employee
$98,377
Profitable Years
2
ROA
3.91
Roa5y
-2.57
ROCE
6.24
ROE
18.37
Roe5y
-1.28
ROIC
9.84
Roic5y
-42.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr1y
-71.74%
Cagr3y
-45.74%
Cagr5y
-25.64%
EPS Growth
106.4
EPS Growth Years
3
FCF Growth
22.65%
FCF Growth3 Y
104.31%
OCF Growth
19.05%
OCF Growth3 Y
81.13%
Revenue Growth
8.94x
Revenue Growth Q
1.62x
Revenue Growth Quarters
23x
Revenue Growth Years
10x
Revenue Growth3 Y
25.2x
Revenue Growth5 Y
46.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
$1.11
Assets
$911.4M
Cash
$283.8M
Current Assets
$566.8M
Current Liabilities
$89.4M
Debt
$29.6M
Debt EBITDA
$0.4
Debt Equity
$0.04
Debt FCF
$0.31
Equity
$792.3M
Interest Coverage
374.6
Liabilities
$119M
Long Term Assets
$344.6M
Long Term Liabilities
$29.6M
Net Cash
$254.3M
Net Cash By Market Cap
$19.94
Net Cash Growth
-24.25%
Net Debt EBITDA
$-3.78
Net Debt Equity
$-0.32
Net Debt FCF
$-2.63
Tangible Book Value
$792.3M
Tangible Book Value Per Share
$27.51
WACC
8.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.34
Inventory Turnover
0.98
Net Working Capital
$193.6M
Quick ratio
4.35
Working Capital
$477.4M
Working Capital Turnover
$1.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
4.44%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

40
MetricValue
1Y total return
-71.72%
200-day SMA
81.24
3Y total return
-84.03%
50-day SMA
55.49
50-day SMA vs 200-day SMA
50under200
5Y total return
-77.26%
All Time High
330
All Time High Change
-86.59%
All Time High Date
2023-07-14
All Time Low
22.5
All Time Low Change
96.71%
All Time Low Date
2018-05-03
ATR
3.41
Beta
0.83
Beta1y
1.03
Beta2y
0.65
Ch YTD
-52.01
High
45.72
High52
161.9
High52 Date
2025-05-13
High52ch
-72.66%
Low
43.99
Low52
43.99
Low52 Date
2026-05-08
Low52ch
0.61%
Ma50ch
-20.24%
Premarket Change Percent
0.2
Premarket Price
$45.66
Premarket Volume
223
Price vs 200-day SMA
-45.52%
RSI
29.85
RSI Monthly
33.94
RSI Weekly
31.28
Sharpe ratio
-1.37x
Sortino ratio
-1.72
Total Return
4.44%
Tr YTD
-52.01
Tr1m
-18.67%
Tr1w
-21.94%
Tr3m
-32.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

14
MetricValue
Analyst Count
16
Analyst Count Top
1
Analyst Price Target Top
$65
Analyst Ratings
Hold
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-0.28
Earnings Revenue Estimate
199,773,456x
Earnings Revenue Estimate Growth
-0.77x
Operating Income
$51.3M
Operating Income Growth
3.02
Operating margin
5.61
Price target
$72.79
Price Target Change
$64.46
Price Target Change Top
$46.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
26,914,591%
Float Percent
93.41%
Shares Insiders
1.27%
Shares Institutions
116.02%
Shares Out
28,813,153
Shares Qo Q
-1.77%
Shares Yo Y
-4.44%
Short Float
10.73%
Short Ratio
2.79
Short Shares
10.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

67
MetricValue
Adjusted FCF
$-33.2M
Average Volume
1,138,961x
Bv Per Share
27.51
CAPEX
$-39.8M
Ch1m
-18.67
Ch1w
-21.94
Ch1y
-71.72
Ch3m
-32.63
Ch3y
-84.03
Ch5y
-77.26
Ch6m
-45.89
Change
-2.87%
Change From Open
-2.32
Close
45.57
Days Gap
-0.57
Depreciation Amortization
16,023,000
Dollar Volume
43,010,407.4
Earnings Date
2026-05-04
Earnings Time
amc
EBIT
$51.3M
EBITDA
$67.3M
EPS
$4.47
F Score
5
FCF
$96.7M
FCF EV Yield
9.47x
FCF Per Share
$3.36
Financing CF
-103,171,000
Fiscal Year End
December
Founded
2,007
Graham Number
52.61521
Graham Upside
18.88
Income Tax
$-67.2M
Investing CF
11,750,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-04
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-13
Ma150
78.01
Ma150ch
-43.27%
Ma20
53.67
Ma20ch
-17.53%
Net CF
45,050,000
Next Earnings Date
2026-08-03
Open
45.31
Optionable
Yes
P FCF Ratio
13.19
P OCF Ratio
9.34
Position In Range
15.61
Post Close
44.26
Postmarket Change Percent
-0.02
Postmarket Price
$44.25
Ppne
123,760,000
Pre Close
45.57
Price Date
2026-05-08
Price EBITDA
$18.94
Ptbv Ratio
1.61
Relative Volume
0.85x
Revenue
915,247,000x
SBC By Revenue
14.19x
Share Based Comp
129,892,000
Tax By Revenue
-7.34x
Tr6m
-45.89%
Us State
Minnesota
Volume
971,767
Z Score
16.83
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does INSP pay a dividend?

Capital-return profile for this ticker.

Performance

INSP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-71.7%
S&P 500 1Y: n/a
3Y total return
-84.0%
S&P 500 3Y: n/a
5Y total return
-77.3%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns INSP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+116.0%
Float: +93.4% of shares outstanding
Insider ownership
+1.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+10.7%
2.8 days to cover
Y/Y dilution
-4.4%
Negative means the company is buying back shares.
Technical

INSP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
29.8
Below 30: short-term oversold
Price vs 200-day MA
-45.5%
50/200-day relationship not available
Beta (5Y)
0.83
Moves roughly with the market
Sharpe ratio
-1.37
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About INSP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INSP stock rating?

Inspire Medical Systems, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INSP analysis?

The full report lives at /stocks/INSP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INSP?

The latest report frames INSP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INSP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.